Wednesday, April 15, 2015 1:17:15 AM
Potentiation of glucose elimination
Document Type and Number:
United States Patent 9006175
Abstract:
Methods related to the treatment of diabetes and improving the efficiency of insulin utilization are provided. The method enables effective control of prandial glucose levels while reducing the risk of postprandial hypoglycemia. In particular, methods of potentiating the activity of endogenous insulin in type 2 diabetics and exogenous long-acting insulin in diabetics requiring basal insulin replacement are provided.
Inventors:
Boss, Anders Hasager (Princeton, NJ, US)
Steiner, Solomon S. (Mount Kisco, NY, US)
Woods, Rodney J. (New Hampton, NY, US)
Sulner, Joseph W. (Paramus, NJ, US)
Application Number:
11/329686
Publication Date:
04/14/2015
Filing Date:
01/10/2006
View Patent Images:
Download PDF 9006175 PDF help
Export Citation:
Click for automatic bibliography generation
Assignee:
MannKind Corporation (Valencia, CA, US)
Primary Class:
514/5.9
Other Classes:
514/6.8, 514/6.9, 514/866, 424/489
International Classes:
A61K38/28; A61K9/72; A61P3/08; A61K9/00; A61K9/14
http://www.freepatentsonline.com/9006175.html
Document Type and Number:
United States Patent 9006175
Abstract:
Methods related to the treatment of diabetes and improving the efficiency of insulin utilization are provided. The method enables effective control of prandial glucose levels while reducing the risk of postprandial hypoglycemia. In particular, methods of potentiating the activity of endogenous insulin in type 2 diabetics and exogenous long-acting insulin in diabetics requiring basal insulin replacement are provided.
Inventors:
Boss, Anders Hasager (Princeton, NJ, US)
Steiner, Solomon S. (Mount Kisco, NY, US)
Woods, Rodney J. (New Hampton, NY, US)
Sulner, Joseph W. (Paramus, NJ, US)
Application Number:
11/329686
Publication Date:
04/14/2015
Filing Date:
01/10/2006
View Patent Images:
Download PDF 9006175 PDF help
Export Citation:
Click for automatic bibliography generation
Assignee:
MannKind Corporation (Valencia, CA, US)
Primary Class:
514/5.9
Other Classes:
514/6.8, 514/6.9, 514/866, 424/489
International Classes:
A61K38/28; A61K9/72; A61P3/08; A61K9/00; A61K9/14
http://www.freepatentsonline.com/9006175.html
Recent MNKD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 01:30:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 01:30:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 01:30:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 01:30:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 01:30:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 01:30:03 AM
- A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. • PR Newswire (Canada) • 03/18/2026 02:00:00 PM
- A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. • PR Newswire (US) • 03/18/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2026 01:30:02 AM
- MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026 • GlobeNewswire Inc. • 03/09/2026 01:05:00 PM
- MannKind Announces Settlement of Convertible Senior Notes • GlobeNewswire Inc. • 03/05/2026 09:30:00 PM
- MannKind to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/04/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:50:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:50:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:50:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 02:50:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 02:50:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 02:50:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 02:50:03 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 01:06:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 01:03:36 PM
- MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
- MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/19/2026 02:00:00 PM
- MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 • GlobeNewswire Inc. • 02/18/2026 02:00:00 PM
- MannKind Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D) • GlobeNewswire Inc. • 02/09/2026 11:05:00 AM
